Trial NCT02346955

View at ClinicalTrials.gov 
Org. Study IDs: 6018-001
Secondary IDs: CB-24-01 MK-6018-001

Last trial update was posted on 2020-08-27

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

Bladder Cancer Colorectal Cancer Gastric Cancer Melanoma Non-small Cell Lung Carcinoma (NSCLC) Ovarian Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID